Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.
Cavelti-Weder C, Timper K, Seelig E, Keller C, Osranek M, Lässing U, Spohn G, Maurer P, Müller P, Jennings GT, Willers J, Saudan P, Donath MY, Bachmann MF.
Cavelti-Weder C, et al. Among authors: lassing u.
Mol Ther. 2016 May;24(5):1003-12. doi: 10.1038/mt.2015.227. Epub 2015 Dec 21.
Mol Ther. 2016.
PMID: 26686385
Free PMC article.
Clinical Trial.